scispace - formally typeset
C

Christian Le Gouill

Researcher at Université de Montréal

Publications -  54
Citations -  2103

Christian Le Gouill is an academic researcher from Université de Montréal. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 26, co-authored 51 publications receiving 1727 citations. Previous affiliations of Christian Le Gouill include Université de Sherbrooke & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET.

TL;DR: New bioluminescence resonance energy transfer (BRET) sensors to quantitatively monitor G protein-coupled receptors (GPCRs) and β-arrestin trafficking are presented and allow quantitative pharmacological studies of GPCR trafficking in real time, in live cells, revealing ligand-dependent biased trafficking of receptor/β-Arrestin complexes.
Journal ArticleDOI

The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors.

TL;DR: The data suggest that the inactivation of the domain, possibly by dephosphorylation, triggers the return of the receptor from the perinuclear compartment to the plasma membrane, which interrupts its transit via the “long cycle.”
Journal ArticleDOI

Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands

TL;DR: The potencies and efficacies of a panel of EP4 ligands for activation of Gαs, Gαi, and β-arrestin relative to the endogenous ligand PGE2 are determined and suggest considerable functional selectivity among the tested, structurally related agonists.
Journal ArticleDOI

Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity

TL;DR: This pharmacological chaperone may represent a candidate for the development of a targeted therapy suitable for a large subset of patients with MC4R-deficient obesity, and suggest a structure-activity relationship between compounds and mutant receptor conformations that may open a path toward personalized therapy.